AuditorApr 20, 2026, 04:06 PM
Damora Therapeutics Dismisses EY Denmark as Auditor
AI Summary
Damora Therapeutics, Inc. announced the dismissal of EY Godkendt Revisionspartnerselskab (EY Denmark) as its independent registered public accounting firm, effective April 17, 2026. EY Denmark had been the company's auditor since 2019. The company stated that there were no disagreements or reportable events with EY Denmark during the two most recent fiscal years and the subsequent interim period. EY Denmark's reports for fiscal years 2025 and 2024 did not contain adverse opinions, though the 2024 report included an explanatory paragraph regarding the company's ability to continue as a going concern.
Key Highlights
- Damora Therapeutics dismissed EY Denmark as its independent auditor on April 17, 2026.
- EY Denmark had served as the company's auditor since 2019.
- No disagreements or reportable events were cited for the dismissal.
- EY Denmark's FY2024 report included a going concern explanatory paragraph.
Price Impact
More from DMRA